Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

[1]  R A Deyo,et al.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.

[2]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[3]  B. Psaty,et al.  The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. , 1990, JAMA.

[4]  B. Strom,et al.  Use of automated databases for pharmacoepidemiology research. , 1990, Epidemiologic reviews.

[5]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[6]  S. Hussain,et al.  Acute renal failure after infusion of gelatins. , 1989, BMJ.

[7]  B. Psaty,et al.  β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure , 1989 .

[8]  S. Harlow,et al.  Agreement between questionnaire data and medical records. The evidence for accuracy of recall. , 1989, American journal of epidemiology.

[9]  J. Kotzan,et al.  Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients. , 1989, American journal of hospital pharmacy.

[10]  J. Feussner,et al.  Blood alcohol measurements in the emergency department: who needs them? , 1988, American journal of public health.

[11]  M. Smyer,et al.  Validation of two methods of data collection of self-reported medicine use among the elderly. , 1988, The Gerontologist.

[12]  T D Koepsell,et al.  A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation , 1988, Medical care.

[13]  K. O’malley,et al.  Prescribing for the Elderly: Part II Prescribing Patterns: Differences Due to Age , 1988, Journal of the American Geriatrics Society.

[14]  J. Staessen,et al.  Mortality in various intervention trials in elderly hypertensive patients: a review. , 1988, European heart journal.

[15]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[16]  J. Fleiss.  The design and analysis of clinical experiments , 1987 .

[17]  C J McDonald,et al.  Diuretic-induced laboratory abnormalities that predict ventricular ectopy. , 1986, Journal of chronic diseases.

[18]  B Rosner,et al.  A prospective study of postmenopausal estrogen therapy and coronary heart disease. , 1985, The New England journal of medicine.

[19]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[20]  E. Barrett-Connor,et al.  Noncontraceptive estrogen use and cardiovascular disease. , 1985, Epidemiologic reviews.

[21]  E. Barrett-Connor,et al.  Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. , 1983, JAMA.

[22]  A. Paganini-Hill,et al.  Reliability of recall of drug usage and other health-related information. , 1982, American journal of epidemiology.

[23]  W. Hale,et al.  Prescribed and Nonprescribed Drug Use in an Ambulatory Elderly Population , 1982, Southern medical journal.

[24]  S. E. Dietert,et al.  Noncontraceptive estrogen use and the occurrence of ovarian cancer. , 1982, Journal of the National Cancer Institute.

[25]  W. Carter,et al.  Variations in Patient Compliance with Common Long-Term Drugs , 1980, Medical care.

[26]  N. Weiss,et al.  Incidence of endometrial cancer in relation to the use of oral contraceptives. , 1980, The New England journal of medicine.

[27]  J. Venulet,et al.  Drug Recording and Classification by the WHO Research Centre for International Monitoring of Adverse Reactions to Drugs , 1974, Methods of Information in Medicine.

[28]  W. Conover.  Statistical Methods for Rates and Proportions , 1974 .